background
patient
copd
frequent
exacerb
role
respiratori
viral
infect
emerg
wish
determin
prospect
incid
viral
infect
exacerb
stabl
copd
patient
well
smoker
airway
obstruct
method
stabl
exacerb
copd
patient
recruit
along
group
patient
smoke
airway
obstruct
spirometri
perform
sputum
specimen
test
rang
differ
respiratori
virus
use
pcr
result
one
hundr
thirtysix
patient
exacerb
copd
stabl
copd
patient
nonobstruct
smoker
recruit
respiratori
viru
detect
exacerb
stabl
copd
patient
nonobstruct
smoker
p
rhinoviru
frequent
detect
symptom
fever
associ
viru
detect
p
infect
one
viru
found
exacerb
copd
patient
conclus
respiratori
viral
infect
associ
exacerb
copd
rhinoviru
common
infect
agent
identifi
two
case
human
metapneumoviru
also
detect
dual
infect
seen
amongst
patient
admit
hospit
acut
exacerb
copd
virus
commonli
detect
sever
airway
diseas
v
l
b
l
e
w
w
w
c
e
n
c
e
r
e
c
c
j
u
r
n
l
h
e
p
g
e
w
w
w
e
l
e
v
e
r
c
l
c
e
r
e
respiratori
medicin
patient
copd
frequent
exacerb
lead
increas
airway
inflamm
often
subsequ
hospit
bacteria
associ
approxim
exacerb
number
studi
identifi
viral
infect
respiratori
tract
precipit
agent
studi
use
serolog
viral
cultur
identifi
respiratori
virus
patient
acut
exacerb
copd
develop
sensit
molecular
test
role
virus
copd
better
defin
walsh
et
al
identifi
sever
common
respiratori
virus
cohort
patient
copd
congest
cardiac
failur
virus
identifi
serolog
viral
cultur
method
signific
outcom
term
hospitalis
seen
respiratori
syncyti
viru
rsv
influenza
infect
patient
greenberg
et
al
use
serolog
viral
cultur
show
case
hospitalis
copd
patient
viru
detect
mean
time
return
symptomat
baselin
week
common
virus
identifi
picornaviru
classif
rhinovirus
sever
studi
use
pcr
diagnosi
viral
infect
initi
seemung
et
al
examin
patient
copd
stabl
subsequ
exacerb
ten
exacerb
associ
rhinoviru
infect
higher
symptom
score
sputum
level
seen
rhinoviru
exacerb
seemung
et
al
went
show
respiratori
viral
infect
exacerb
copd
viral
infect
associ
sever
exacerb
patient
higher
frequenc
exacerb
ie
poorest
lung
function
patient
review
convalesc
week
major
virus
rhinoviru
ie
copd
exacerb
plasma
level
elev
exacerb
level
significantli
increas
viru
posit
group
comparison
made
viru
detect
rohd
et
al
use
pcr
detect
virus
patient
exacerb
copd
respiratori
viru
detect
case
comparison
control
subject
stabl
copd
major
virus
detect
picornavirus
recent
studi
beckham
et
al
combin
specimen
obtain
two
previou
studi
analysi
pcr
detect
respiratori
viral
infect
acut
respiratori
ill
respiratori
viral
infect
copd
patient
exacerb
associ
longer
median
symptom
recoveri
time
comparison
exacerb
viral
agent
identifi
day
versu
day
respect
hypothesi
test
present
studi
acut
respiratori
viral
infect
implic
pathogenesi
copd
exacerb
aim
present
studi
examin
respiratori
specimen
presenc
respiratori
virus
patient
copd
whilst
stabl
also
exacerb
studi
approv
queen
univers
belfast
ethic
committe
patient
gave
written
consent
patient
group
describ
paper
describ
relat
public
patient
hospitalis
exacerb
copd
recruit
within
h
present
period
group
stabl
copd
patient
also
recruit
stabil
defin
chang
respiratori
symptom
alter
therapi
previou
week
patient
symptom
record
binari
format
spirometri
perform
best
reproduc
read
taken
vitalograph
spiromet
vitalograph
buckingham
uk
spirometri
repeat
nebulis
beta
agonist
salbutamol
mg
patient
signific
improv
fev
ml
exclud
patient
histori
bronchiectasi
neoplast
process
seriou
concomit
diseas
exclud
copd
assess
sever
classifi
accord
gold
criteria
exacerb
copd
classifi
accord
gold
criteria
symptom
increas
dyspnoea
increas
cough
increas
sputum
product
stabl
copd
classifi
accord
gold
criteria
without
symptom
exacerb
chang
treatment
within
last
week
sputum
sampl
obtain
either
spontan
product
follow
nebulis
hyperton
salin
briefli
ml
salin
nebulis
via
air
driven
nebulis
everi
min
spirometri
repeat
measur
fev
nebulis
continu
fev
fallen
continu
min
sputum
expector
collect
sampl
process
within
h
specimen
mix
volum
dithiothreitol
sigma
pool
uk
shaken
orbit
incub
gallenkamp
loughborough
uk
min
c
follow
addit
volum
phosphat
buffer
salin
shaken
min
result
suspens
filter
mm
nylon
gauz
lockertex
warrington
uk
spun
g
min
remov
supernat
cell
pellet
resuspend
lysi
buffer
qiagen
crawley
uk
total
nucleic
acid
extract
perform
ml
sputum
sampl
suspend
lysi
buffer
qiaamp
dna
blood
mini
kit
extract
sampl
screen
common
respiratori
virus
rhinoviru
human
metapneumoviru
influenza
influenza
b
rsv
b
coronaviru
adenoviru
parainfluenza
use
eightwel
multiplex
nest
pcr
system
fig
posit
control
use
set
patient
test
mastermix
pcr
cycl
condit
list
supplementari
materi
appendix
respect
test
result
accept
valid
posit
control
test
posit
correct
size
product
posit
result
note
second
first
second
round
product
note
confirm
correct
size
indetermin
test
result
repeat
method
allow
rapid
test
clinic
specimen
multipl
virus
sensit
specif
assay
power
calcul
perform
determin
studi
group
size
assum
respiratori
viru
detect
rate
amongst
copd
patient
exacerb
detect
stabl
power
calcul
perform
use
version
use
confid
valu
power
ratio
group
size
patient
copd
exacerb
stabl
copd
subject
requir
normal
distribut
data
present
mean
ae
standard
deviat
whilst
nonparametr
data
express
median
inter
quartil
rang
normal
distribut
continu
variabl
compar
ttest
otherwis
differ
assess
mannewhitney
utest
discret
variabl
frequenc
percentag
report
group
compar
use
chi
squar
test
signific
level
chosen
statist
analysi
carri
use
spss
chicago
il
version
total
subject
recruit
studi
tabl
seen
acut
exacerb
recruit
stabl
addit
nonobstruct
smoker
fev
fvc
within
normal
rang
recruit
patient
characterist
shown
tabl
exacerb
stabl
copd
group
similar
age
sex
fev
tobacco
use
baselin
mrc
score
inhal
steroid
bodi
mass
index
bmi
pack
year
tobacco
use
crp
white
cell
count
wcc
significantli
elev
exacerb
compar
stabl
copd
patient
crp
level
mgdl
mgdl
exacerb
mgdl
mgdl
stabl
patient
p
wcc
increas
ae
ae
l
exacerb
copd
p
similarli
neutrophil
count
increas
ae
major
patient
describ
symptom
increas
dyspnoea
cough
along
increas
sputum
volum
purul
exacerb
tabl
presenc
fever
associ
identif
patient
p
major
patient
mrc
score
exacerb
respiratori
virus
detect
sputum
nasal
throat
swab
patient
exacerb
copd
stabl
copd
patient
p
tabl
virus
detect
tabl
rhinoviru
adenoviru
parainfluenza
influenza
rsv
b
metapneumoviru
coronaviru
rsv
dual
infect
six
case
howev
confin
exacerb
copd
group
respiratori
viru
frequent
detect
exacerb
patient
sever
airway
diseas
p
tabl
associ
seen
viral
infect
patient
sex
medic
use
theophyllin
inhal
steroid
therapi
main
find
studi
respiratori
virus
frequent
detect
acut
exacerb
copd
patient
admit
hospit
crp
level
correl
exacerb
durat
hospit
stay
studi
perform
period
order
avoid
bia
due
season
detect
rate
respiratori
virus
exacerb
copd
studi
compar
result
obtain
seemung
lower
detect
rate
may
relat
time
sampl
patient
present
hospit
develop
symptom
median
day
prior
admiss
first
studi
prospect
analys
rang
respiratori
virus
patient
recruit
exacerb
copd
common
infect
agent
rhinoviru
keep
previou
studi
howev
also
detect
high
rate
adenovir
infect
previous
report
keep
find
coyl
et
al
demonstr
adenoviru
commonli
detect
use
pcr
convent
immunofluoresc
viru
cultur
techniqu
previou
investig
relat
adenovir
infect
subsequ
latent
infect
form
adenoviru
may
import
pathogenesi
copd
metapneumoviru
discov
initi
detect
young
children
respiratori
tract
ill
subsequ
found
play
role
communityacquir
respiratori
tract
ill
patient
present
influenzalik
ill
test
posit
beckham
et
al
test
specimen
patient
exacerb
copd
stabl
metapneumoviru
patient
neg
rohd
et
al
found
metapneumoviru
present
patient
acut
exacerb
copd
none
stabl
copd
patient
keep
find
studi
detect
human
metapneumoviru
studi
confirm
role
respiratori
pathogen
adult
patient
copd
studi
show
rel
lower
detect
rate
influenza
viru
compar
studi
may
relat
improv
vaccin
amongst
group
risk
individu
may
also
reflect
recruit
studi
influenza
epidem
also
lower
incid
rsv
infect
case
previou
investig
suggest
common
suggest
present
low
copi
number
possibl
sensit
realtim
pcr
assay
requir
order
detect
howev
recent
studi
suggest
rsv
account
copd
admiss
hospitalis
patient
first
studi
also
includ
group
patient
commun
respiratori
diseas
nonobstruct
smoker
similar
detect
rate
respiratori
virus
stabl
copd
no
group
support
previou
find
found
respiratori
viral
infect
present
asymptomat
individu
frequenc
detect
group
suggest
copd
patient
higher
carriag
rate
viral
infect
no
larger
studi
requir
order
confirm
one
weak
studi
patient
recruit
follow
admiss
hospit
case
may
sever
day
infect
develop
symptom
present
depend
durat
viral
infect
prior
seek
medic
help
may
case
patient
present
late
thu
viral
replic
decreas
result
reduc
detect
rate
may
lead
underestim
preval
viral
infect
patient
recent
public
also
suggest
rsv
detect
increas
use
realtim
pcr
assay
respiratori
viral
assay
studi
util
nest
pcr
technolog
realtim
pcr
method
detect
respiratori
virus
pcr
may
fact
relat
airway
colon
viral
persist
howev
sever
patient
seen
differ
time
point
studi
viru
detect
repeat
sampl
suggest
test
posit
use
pcr
screen
experienc
acut
viral
infect
anoth
possibl
confound
factor
patient
copd
experi
exacerb
precipit
agent
identifi
episod
may
relat
progress
natur
diseas
process
rather
acut
event
thu
true
role
respiratori
viral
infect
exacerb
may
underestim
possibl
area
bia
patient
recruit
hospit
thu
select
bia
may
impos
patient
admit
hospit
tend
particular
type
respiratori
viral
infect
respiratori
viral
infect
precipit
exacerb
subsequ
hospit
admiss
patient
sever
copd
anoth
potenti
sourc
bia
season
respiratori
viral
infect
address
issu
recruit
patient
month
year
period
potenti
sourc
bia
includ
patient
select
patient
ill
requir
noninvas
ventil
ill
particip
studi
thompson
et
al
publish
data
link
influenza
rsv
infect
increas
mortal
elderli
increas
admiss
older
peopl
winter
fleme
show
acut
respiratori
infect
associ
hospitalis
increas
mortal
reinforc
health
servic
implic
winter
infect
increas
exacerb
copd
also
noteworthi
peak
death
rate
patient
diagnos
acut
respiratori
diseas
influenza
link
increas
health
care
use
elderli
excess
mortal
particularli
elderli
paper
highlight
impact
respiratori
viral
infect
health
care
resourc
support
use
influenza
vaccin
patient
underli
respiratori
diseas
order
reduc
exacerb
hospit
admiss
conclus
studi
support
hypothesi
respiratori
viral
infect
associ
exacerb
copd
rhinoviru
common
infect
agent
identifi
two
case
human
metapneumoviru
also
detect
dual
infect
seen
amongst
patient
admit
hospit
acut
exacerb
copd
develop
multiplex
realtim
pcr
assay
enabl
technolog
util
acut
diagnost
set
